Cargando…
Rapid testing versus karyotyping in Down's syndrome screening: cost-effectiveness and detection of clinically significant chromosome abnormalities
In all, 80% of antenatal karyotypes are generated by Down's syndrome screening programmes (DSSP). After a positive screening, women are offered prenatal foetus karyotyping, the gold standard. Reliable molecular methods for rapid aneuploidy diagnosis (RAD: fluorescence in situ hybridization (FIS...
Autores principales: | Gekas, Jean, van den Berg, David-Gradus, Durand, Audrey, Vallée, Maud, Wildschut, Hajo Izaäk Johannes, Bujold, Emmanuel, Forest, Jean-Claude, Rousseau, François, Reinharz, Daniel |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039505/ https://www.ncbi.nlm.nih.gov/pubmed/20842178 http://dx.doi.org/10.1038/ejhg.2010.138 |
Ejemplares similares
-
Comparison of different strategies in prenatal screening for Down’s syndrome: cost effectiveness analysis of computer simulation
por: Gekas, Jean, et al.
Publicado: (2009) -
Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issues
por: Gekas, Jean, et al.
Publicado: (2016) -
Identification of trisomy 18, trisomy 13, and Down syndrome from maternal plasma
por: Gekas, Jean, et al.
Publicado: (2014) -
Application of chromosome microarray analysis and karyotyping in diagnostic assessment of abnormal Down syndrome screening results
por: Kang, Han, et al.
Publicado: (2022) -
Molecular microdeletion analysis of infertile men with karyotypic Y chromosome abnormalities
por: Pan, Yuan, et al.
Publicado: (2017)